Patent details
EP2228064 Title: Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist
Basic Information
- Publication number:
- EP2228064
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP101649762
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist
- French Title of Invention:
- Composition pharmaceutique comprenant du glycopyrrolate et un agoniste du récepteur beta2 adrénergique
- German Title of Invention:
- Pharmazeutische Zusammensetzung enthaltend Glykopyrrolat und einen Beta2-adrenoceptor Antagonisten
- SPC Number:
-
LUC00155
Dates
- Filing date:
- 17/05/2005
- Grant date:
- 11/12/2019
- EP Publication Date:
- 15/09/2010
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 11/12/2019
- EP B1 Publication Date:
- 11/12/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 17/05/2025
- Renunciation date:
- Revocation date:
- 07/10/2025
- Annulment date:
Owner
- From:
- 23/06/2023
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
History of Owners
- From:
- 04/12/2019
- To:
- 23/06/2023
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
- Name:
- Collingwood, Stephen Paul
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 0411056
- Priority Date:
- 18/05/2004
- Priority Country:
- United Kingdom (GB)
Classification
- IPC classification:
- A61K 31/402; A61K 31/4704; A61P 11/00;
Publication
European Patent Bulletin
1
- Issue number:
- 201950
- Publication date:
- 11/12/2019
- Description:
- Grant (B1)
2
- Issue number:
- 202042
- Publication date:
- 14/10/2020
- Description:
- Opposition procedure started
3
- Issue number:
- 202551
- Publication date:
- 17/12/2025
- Description:
- Revocation of the European patent
4
- Issue number:
- 202330
- Publication date:
- 26/07/2023
- Description:
- Transfer of Rights
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 13/05/2024
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 300 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|